Cargando…
A new treatment approach – Eplerenone - in central serous chorioretinopathy - Case report
We report the case of a 46-year-old patient, medical doctor with a relapsing unilateral CRSC-Central Serous Chorioretinopathy who was treated after an initial medical therapy (oral carbonic anhydrase inhibitor, oral antihistamines, non-steroidal anti-inflammatory drugs - systemic and topical), with...
Autores principales: | Cioboata, M, Alexandrescu, C, Hopinca, CA, Pienaru, MC, Merticariu, A, Schmitzer, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052491/ https://www.ncbi.nlm.nih.gov/pubmed/27713772 |
Ejemplares similares
-
Eplerenone Treatment in Chronic Central Serous Chorioretinopathy
por: Iqbal, Faisal, et al.
Publicado: (2021) -
Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature
por: Chatziralli, Irini, et al.
Publicado: (2018) -
Lack of efficacy of eplerenone for treatment of active central serous chorioretinopathy
por: Sadda, Srinivas R.
Publicado: (2020) -
Bilateral bullous central serous chorioretinopathy treated with PDT and eplerenone
por: Anderson, William J., et al.
Publicado: (2022) -
Real-world practice patterns of eplerenone use for central serous chorioretinopathy
por: Venkatesh, Ramesh, et al.
Publicado: (2023)